Comparing Heparin-Coated and Non-Coated Oxygenators On Renal Functions in Coronary Artery Bypass Surgery

Yıl 2011, Cilt: 14 Sayı: 1, 6 - 11, 01.01.2010

Nevzat Erdil Nihat Aydın Tamer Eroğlu Murat Kaynak Köksal Dönmez Fulya Erbaş Bektaş Battaloğlu Saim Yoloğlu

Öz

Background: Renal damage and subsequent acute renal failure is one of the most important complications in patients who had cardiac surgery. Multicenter studies with thousands of patients which exposed the risk factors for acute renal failure has been published especially in the last decade. This study is designed for evaluation of heparin-coated and non-coated oxygenators on the renal functions. Methods: This study has been performed prospectively with 50 patients who had undergone coronary bypass surgery in our clinic from March 2006 to September 2006. The patients have been divided into two groups as non-coated oxygenators (n = 25, Group 1) used and heparin-coated oxygenators (n = 25, Group 2) used. Blood samples were collected at the preoperative, and at 1st, 24th and 96th postoperative hours. The demographic data were similar in two groups. Results: There was no early mortality in both groups. Operative and postoperative parameters were similar in both groups. There were no statistical differences between the evaluated parameters like BUN, creatinine, sodium, potassium, calcium, chloride, phosphorus, urine protein, creatinine clearence, urine sodium, urine calcium and urine chloride tests at preoperative period in both groups. We did not detect renal dysfunction in any patients. There are no statistical differences in the creatinine clearance in preoperative and postoperative periods in both groups. In group one, creatinin levels were lower than group two at 24 hours after surgery and these differences were statistically important in two groups. We found no significant difference between two groups regarding the other parameters for renal function during the postoperative period. Conclusion: In this study, there were not any significant difference between coated and non-coated oxygenators' effects over renal functions of patients whose renal functions were normal preoperatively.

Anahtar Kelimeler

Coronary artery bypass surgery, cardiopulmonary bypass, oxygenators, membrane, kidney failure.

Koroner Arter Baypas Cerrahisinde Kullanılan Heparin Kaplı Olan ve Olmayan Oksijenatörlerin Böbrek Fonksiyonları Üzerine Olan Etkisinin Karşılaştırılması

Öz

Amaç: Renal hasar ve takiben oluşan akut böbrek yetmezliği kardiyak cerrahiye giden hastalarda görülen en önemli komplikasyonlardan birisidir. Özellikle son on yılda yayınlanan çok merkezli ve binlerce hastayı kapsayan çalışmalarda akut renal yetmezlik için risk faktörleri ortaya konmaktadır. Bu çalışmanın amacı heparin kaplı olan ve olmayan oksijenatörlerin renal fonksiyonlar üzerine etkisini değerlendirmektir. Metod: Kliniğimizde Mart 2006 ile Kasım 2006 tarihleri arasında koroner bypass operasyonuna giden 50 hasta prospektif olarak çalışmaya dahil edilmiştir. Hastalar heparin kaplı olmayan oksijenatör kullanılan (n=25, Grup 1) ve heparin kaplı oksijenatör kullanılan (n=25, Grup 2) olmak üzere iki gruba ayrılmıştır. Kan örnekleri preoperatif ve postoperatif 1, 24 ve 96. saatte alınmıştır. Alınan kan örneklerinden BUN, kreatinin, sodyum, potasyum, kalsiyum, klor ve fosfor; idrar örneklerinden ise protein, klirens, sodyum, kalsiyum ve klor çalışılmıştır. Her iki grupta demografik veriler benzerdir. Sonuçlar: Her iki grupta da erken mortalite yoktu. Operatif ve postoperatif parametreler her iki grupta da benzerdir. Her iki grupta preoperatif periodda değerlendirilen parametreler olan BUN, kreatinin, sodyum, potasyum, kalsiyum, klor, fosfor, idrar proteini, idrar klirensi, idrar sodyumu, idrar kalsiyumu ve idrar kloru açısından istatiksel olarak anlamlı değişiklik yoktu. Hiçbir hastada renal disfonksiyon saptanmadı. Her iki grupta preoperatif ve postoperatif periyotta ölçülen idrar klirensi istatiksel olarak anlamlı değişiklik göstermemektedir. Grup I'de cerrahi sonrası 24. saatte ölçülen kreatinin değeri Grup II'den daha düşük olarak bulunmuştur ve bu değişiklik istatistiksel açıdan anlamlı idi. Her iki grupta postoperatif periyotta renal fonksiyonları değerlendirmek için kullanılan diğer parametrelere bakıldığında anlamlı bir farklılık bulunmadı. Tartışma: Bu çalışmada preoperatif böbrek fonksiyonları normal hastalarda, heparin kaplı olan ve olmayan oksijenatörlerin böbrek fonksiyonları üzerine olan etkilerinde bir farklılık saptanmadı.

Anahtar Kelimeler

Koroner arter baypas cerrahisi, kardiyopulmoner baypas, oksijenatör, membran, böbrek yetmezliği.

Kaynakça

• Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993;55:552-9
• Casey LC. Role of cytokines in the pathogenesis of cardio- pulmonary –induced multisystem organ failure. Ann Thorac Surg 1993;56:S92-6.
• Windsor AC, Mullen PG, Fowler AA, Sugerman HJ. Role of the neutrophil in adult respiratory distress syndrome Br J Surg 1993;80:10-7.
• Kirklin JK. Prospects for understanding and eliminating the de- leterious effects of cardiopulmonary bypass. Ann Thorac Surg 1991;51:529-31.
• Gu YJ, Van Oeveren W, Akkerman C, Boonstra PW, Huyzen RJ, Wildevuur CR. Heparin-coated circuits reduce the inflam- matory response to cardiopulmonary bypass Ann Thorac Surg 1993;55:917-22.
• Jones DR, Hill RC, Vasilakis A, Hollingsed MJ, Graeber GM, Gustafson RA, et al. Safe use of heparin-coated bypass circu- its incorporating a pump-oxygenator Ann Thorac Surg 1994;57:815-9.
• Kirklin JK, Kirklin JW. Cardiopulmonary bypass for cardiac sur- gery. In: Sabiston DC Jr, Spencer FC, eds. Surgery of the chest, 5th ed. Philadelphia: WB Saunders, 1990; pp 1107-25.
• Elgebaly SA, Houser SL, el Kerm AF, Doyle K, Gillies C, Da- lecki K. Evidence of cardiac inflammation after open heart ope- rations. Ann Thorac Surg 1994; 57:391-6.
• Cremer J, Martin M, Redl H, Bahrami S, Abraham C, Grae- ter T, et al. Systemic inflammatory response syndrome after car- diac operations. Ann Thorac Surg 1996; 61:1714-20.
• Michelson AD, MacGregor H, Barnard MR, Kestin AS, Roh- rer MJ, Valeri CR. Reversibl inhibition of human platelet activa- tion by hypotermia in vivo and an vitro. Trombosis and hae- mostasis 1994;71:633-40.
• Khuri SF, Valeri CR, Loscalzo J, Weinstein MJ, Birjiniuk V, Hea- ley NA, et al. Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg 1995;60:1008-14.
• Reichenspurner H, Navia JA, Berry G, Robbins RC, Barbut D, Gold JP, et al. Particulate emboli capture by an intra-aortic fitler device during cardiac surgery. J Thorac Cardiovasc Surg 2000;119:233-41.
• Brown Mahoney C, Donnelly J. Impact of closed versus open venous reservoirs on patient outcomes in isolated coronary ar- tery bypass graft surgery. Perfusion 2000;15:467-72.
• Jansen NJ, van Oeveren W, Gu YJ, van Villiet MH, Eijsman L, Wildevuur CR. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg 1992; 54:744-8.
• Zehr KJ, Poston RS, Lee PC, Uthoff K, Kumar P, Cho PW, et al. Platelet activating factor inhibition reduces lung injury af- ter cardiopulmonary bypass. Ann Thorac Surg 1995; 59:328-35. 16. Chertow GM, Lazarus JM, Christiansen CL, Cook EF, Hammermeister KE, Grover F, et al . Preoperative renal risk stra- tification. Circulation 1997; 95: 878-84.
• Zanardo G, Michielon P, Paccagnella A, Rosi P, Calo M, Sa- landin V, et al. Acute renal failure in the patient undergoing car- diac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg 1994; 107:1489-95.
• Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mor- tality following cardiac surgery. Am J Med 1998; 104: 343-8.
• Weerasinghe A, Hornick P, Smith P, Taylor K, Ratnatunga C. Coronary artery bypass grafting in non-dialysis-dependent mild-to-moderate renal dysfunction. J Thorac Cardiovasc Surg 2001; 121:1083-9.
• Zakeri R, Freemantle N, Barnett V, Lipkin GW, Bonser RS, Graham TR, et al . Relation between mild renal dysfunction and outcomes after coronary artery bypass grafting. Circulation 2005; 12: I270-5.
• van de Wal RM, van Brussel BL, Voors AA, Smilde TD, Kel- der JC, van Swieten HA, et al . Mild preoperative renal dysfunc- tion as a predictor of long-term clinical outcome after coronary bypass surgery. J Thorac Cardiovasc Surg 2005; 129: 330-5. 22. Hilberman M, Derby GC, Spencer RJ, Stinson EB. Sequential pathophysiological changes characterizing the progression from renal dysfunction to acute renal failure following cardiac ope- ration. J Thorac Cardiovasc Surg 1980; 79: 838-44.
• Boldt J, Brenner T, Lehmann A, Suttner SW, Kumle B, Is- gro F. Is kidney function altered by the duration of cardiopulmonary bypass? Ann Thorac Surg 2003; 75: 906-12.
• Bove T, Calabro MG, Landoni G, Aletti G, Marino G, Cres- cenzi G, et al . The incidence and risk of acute renal failure after cardiac surgery. J Cardiothorac Vasc Anesth 2004; 18: 442-5 25. Hsu LC. Heparin-coated cardiopulmonary bypass circuits: current status. Perfusion 2001;16:417-28.
• Ranucci M, Mazzucco A, Pessotto R, Grillone G, Casati V, Porreca L, et al. Heparin-coated circuits for high-risk patients: a multicenter, prospective, randomized trial. Ann Thorac Surg 1999;67:994-1000.